Phase 4 Completed N=34 Treatment

Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL

Cataracts

Source: ClinicalTrials.gov NCT00818116 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2010

Primary outcomePrimary: Uncorrected and Best Corrected Visual Acuities (Near and Distance) — 0.02; 0.01; 0.00; -0.03 logMAR

Summary

The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).

Outcome Measures

Outcome	Result	p-value
PRIMARY Uncorrected and Best Corrected Visual Acuities (Near and Distance)	0.02; 0.01; 0.00; -0.03	—

Eligibility Criteria

Inclusion Criteria

Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
50~75 years of age
<1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.

Exclusion Criteria

Patients with pre-existing conditions that could skew the results.
Any of conditions before and during surgery specified in the product information.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00818116). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.